Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Theory of knowledge and biotech patents: worlds apart?

The development of original research requires tacit as well as explicit knowledge, which allows for the establishment of new epistemic trajectories with novel epistemic horizons. Much of the tacit knowledge involved in the innovation process can be transmitted as explicit knowledge through the patent document.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The innovation process has different stages that dynamically connect the conditions in which the problem is set with the results and the impact that the invention has (e.g., the patent and the knowledge related to it).

References

  1. Mills, A.E. & Tereskerz, P.M. Nat. Biotechnol. 28, 325–328 (2010).

    Article  CAS  Google Scholar 

  2. Aghion, P., Dewatripont, M., Hoxby, C., Mas-Colell, A. & Sapir, A. Econ. Policy 25, 7–59 (2010).

    Article  Google Scholar 

  3. Henderson, R., Jaffe, A. & Trajtenberg, M. Am. Econ. Rev. 95, 461–464 (2005).

    Article  Google Scholar 

  4. La Montagne, J.R. Lancet 358, 1723–1724 (2001).

    Article  CAS  Google Scholar 

  5. Joly, Y. Nat. Biotechnol. 28, 417–419 (2010).

    Article  CAS  Google Scholar 

  6. World Intellectual Property Organization. WIPO Intellectual Property Handbook Policy, Law and Use (World Intellectual Property Organization, Geneva, 2004).

  7. European Parliament and European Union Council. Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions (Official Journal of the European Communities, Brussels, 1998).

  8. Elliott, G. AAPS J. 9, E317–E324 (2007).

    Article  CAS  Google Scholar 

  9. Stefik, M. & Stefik, B. Breakthrough! Stories and Strategies of Radical Innovation, pp. 69–70.

  10. Echeverría, J. Arbor 184, 609–618 (2008).

    Google Scholar 

  11. Simmons, W.J. Nat. Biotechnol. 28, 801–805 (2010).

    Article  CAS  Google Scholar 

  12. Polanyi, M. Personal Knowledge (Routledge, Keagan & Paul, London, 1962).

    Google Scholar 

  13. Collins, M. Soc. Stud. Sci. 31, 71–85 (2001).

    Article  Google Scholar 

  14. Ibarra, A. Redes epistémicas. Nuevos sujetos de la ciencia en nuevos modos de acción cognitiva. in La ciencia y Sus Sujetos (ed. Broncano, F. & Pérez Ransanz, A.R.) 135–158 (Siglo XXI-UNAM, México, 2009).

    Google Scholar 

  15. Das, O.P. Nat. Biotechnol. 23, 781–783 (2005).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the funding provided to the project 068673 by Mexico's Council for Science and Technology (CONACYT) and Institute of Science and Technology of Mexico City (ICYTDF). The authors are also indebted to the Education, Research and Health Politics Unit; Research Coordination and the Research Unit of Metabolic Diseases of Mexican Institute of Social Security, Mexico City, Mexico for their support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to León Olivé.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Altamirano-Bustamante, M., de Hoyos, A. & Olivé, L. Theory of knowledge and biotech patents: worlds apart?. Nat Biotechnol 29, 977–978 (2011). https://doi.org/10.1038/nbt.2026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2026

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research